Top industry leaders, investors, and entrepreneurs will converge to explore “#TheNext10” years of life science innovation at the Council for Entrepreneurial Development (CED) Life Science Conference, March 3–4 in Raleigh, N.C.
The 2015 conference will cover the latest developments and trends in patient advocacy, personalized medicine, digital health, and venture funding and their transformative effect on the life science landscape over the next decade. The conference, which attracts nearly 1,000 industry, research, investor and business organizations, will feature some of the most celebrated names in life science:
- Herb Boyer, co-founder of Genentech
- John Lechleiter, CEO, president, & chairman, Eli Lilly & Co.
- Dennis Gillings, founder and executive chairman, Quintiles
Several of the country’s most notable investors will also attend and take the stage:
- Steve Bloch, general partner, Canaan Partners
- Leslie Bottorff, managing director, GE Ventures
- Fred Cohen, partner and managing director, TPG Biotech
“This year’s roster of companies and speakers are the scientists, innovators and visionaries who are using science and technology to make our lives better – and change the world,” said Joan Siefert Rose, president of CED. “They are transforming every aspect of our lives, from how we interact with our health care providers, to making treatments less invasive, to designing and refining the technology that improves and extends our lives. These leaders are proof that North Carolina is on the cutting edge of the next 10 years of innovation in the life science industry.”
The conference will showcase 13 of North Carolina’s most disruptive and exciting life science innovators, along with 50 of the top emerging companies in the region chosen to demonstrate in #TheNext10 Innovation Room, open at select times throughout the conference.
The widely attended conference enables North Carolina life science entrepreneurs to connect with hundreds of venture capital, angel, and strategic investors from around the nation. The conference is presented in partnership with the North Carolina Biotechnology Center and NCBIO. It will be held March 3–4 at the Raleigh Convention Center.
“We’re pleased to continue our partnership with the Council for Entrepreneurial Development and NCBIO, to once again bring together North Carolina’s vibrant life science community for this, the CED Life Science Conference 2015,” said Doug Edgeton, president and CEO of NCBiotech. “Excellent leadership and programming are the hallmark of this annual event, and enthusiastic participation its result. Virtually everyone who experiences it agrees that this is the leading life science conference in the Southeast.”
Sam Taylor, president of NCBIO, agreed that the region is a hotbed for life science innovation. “North Carolina is transforming life science innovation,” Taylor said. “This year’s CED Life Science Conference 2015 couldn’t come at a more exciting time – when we can get a glimpse of how the region is shaping the future of the life science industry over the next 10 years.”
The conference will feature keynotes from Herb Boyer, John Lechleiter and Dennis Gillings, and will include the following conference segments:
- Disruptive Models in Venture Philanthropy & Patient Advocacy
- The Next 10 – Strategies and Trends in a Changing Landscape
- The Future of Personalized Medicine
- Funding Innovation in the Life Sciences
The full conference agenda can be found at: www.cednc.org/lifescience/agenda.
The showcase and demo companies hail from across the state, including: Raleigh, Durham, Chapel Hill, Cary, Morrisville, Wilmington, Winston-Salem, Burlington, Greenville, and Research Triangle Park.
“This conference brings companies together that are on the cutting edge of pharma, ag-bio, devices, diagnostics and digital health, along with some of the country’s most exciting life science leaders and investors, to look into the future,” said Jay Bigelow, CED’s director of entrepreneurship. “It’s one of the most important events on the calendar in the Southeast.”